BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 22779757)

  • 1. Enhancement of antitumor effects of a new boron compound combined with ultrasound on the mouse ascites tumor.
    Ghosh P; Sur P; Bag SP
    Med Chem; 2012 Nov; 8(6):1026-31. PubMed ID: 22779757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the possible use of a new boron compound, hydroxysalicylhydroxamato boron(III), and ultrasound in the treatment of female mice bearing the Ehrlich ascites carcinoma cells.
    Ghosh P; Sur P; Bag SP; Sur B; Chatterjee SN
    Neoplasma; 1998; 45(6):384-8. PubMed ID: 10210114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the inhibitory activities of a new boron compound and ultrasound against the mouse ascites tumour.
    Sur P; Ghosh P; Bag SP; Sur B; Chatterjee SN
    Chemotherapy; 1999; 45(5):360-9. PubMed ID: 10473924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of antitumor effects of 5-fluorouracil combined with ultrasound on Ehrlich ascites tumor in vivo.
    Mohamed MM; Mohamed MA; Fikry NM
    Ultrasound Med Biol; 2003 Nov; 29(11):1635-43. PubMed ID: 14654158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor properties of boron complexes with hydroxy biguanide and salicyl hydroxamic acid against Ehrlich ascites carcinoma.
    Ghosh P; Bag SP; Sur B; Sur P
    Neoplasma; 1998; 45(2):68-72. PubMed ID: 9687884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new boron compound (guanidine biboric acid adduct) as an antitumour agent against Ehrlich ascites carcinoma in mice.
    Ghosh P; Sur B; Bag SP; Sur P
    Tumour Biol; 1999; 20(1):44-51. PubMed ID: 9858874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promising potential of boron compounds against Glioblastoma: In Vitro antioxidant, anti-inflammatory and anticancer studies.
    Turkez H; Arslan ME; Tatar A; Mardinoglu A
    Neurochem Int; 2021 Oct; 149():105137. PubMed ID: 34293392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Boron betaine analogs: antitumor activity and effects on Ehrlich ascites tumor cell metabolism.
    Hall IH; Starnes CO; Spielvogel BF; Wisian-Neilson P; Das MK; Wojnowich L
    J Pharm Sci; 1979 Jun; 68(6):685-8. PubMed ID: 222887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor effect of carboplatin combined with hyperthermia on Ehrlich-ascites tumor in vivo.
    Mizuuchi H; Yoshiga K; Sakurai K; Tsumura M; Takada K
    Anticancer Res; 1996; 16(1):381-7. PubMed ID: 8615640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chloroaceto hydroxamic acid as antitumor agent against Ehrlich ascites carcinoma in mice.
    Sur P; Bag SP; Sur B; Khanam JA
    Neoplasma; 1997; 44(3):197-201. PubMed ID: 9372863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of three newly synthesized pyrimidine-containing compounds on micronucleus induction and tumor growth.
    Nersesyan A; Muradyan R; Arsenyan F
    J BUON; 2007; 12(4):521-7. PubMed ID: 18067211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor activity of a molecularly imprinted nanopreparation of 5-flurouracil against Ehrlich's carcinoma solid tumors grown in mice: Comparison to free 5-flurouracil.
    Gardouh AR; Barakat BM; Qushawy MKE; El-Kazzaz AY; Sami MM; Zaitone SA
    Chem Biol Interact; 2018 Nov; 295():52-63. PubMed ID: 29678497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of N-(o-methoxyphenyl)-maleimide on 5-fluorouracil cytotoxicity in Ehrlich (ascites) carcinoma.
    Ambaye RY; Indap MA
    Cancer Lett; 1991 Apr; 57(1):21-6. PubMed ID: 1902758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trehalose enhances the antitumor potential of methotrexate against mice bearing Ehrlich ascites carcinoma.
    El-Magd MA; Khamis A; Nasr Eldeen SK; Ibrahim WM; Salama AF
    Biomed Pharmacother; 2017 Aug; 92():870-878. PubMed ID: 28599251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-glycosyl Flavone from Urginea indica Inhibits Growth and Dissemination of Ehrlich Ascites Carcinoma Cells in Mice.
    Bevara GB; Kumar ADN; Koteswramma K L; Badana AK; Kumari S; Yarla NS; Malla RR
    Anticancer Agents Med Chem; 2017; 17(9):1256-1266. PubMed ID: 28044935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoimmunotherapeutic approach to prolonged survival time in combination with immunization and glutamic Acid derivatives with antitumor activity in tumor-bearing mice.
    Samanta S; Alam SM; Basu S; Maji T; Roy DK; Jha T
    Biol Pharm Bull; 2007 Dec; 30(12):2334-9. PubMed ID: 18057722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of 5-fluorouracil in combination with methoxyphenyl maleamic acid in murine tumors.
    Indap MA; Ambaye RY
    J Postgrad Med; 1991 Oct; 37(4):211-5. PubMed ID: 1841970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of antitumor effects of new analogue of platinum, cis-diammine (glycolato) platinum (254-S) combined with hyperthermia in vivo.
    Jo A; Sakurai K; Tsumura M; Mizuuchi H; Yoshiga K; Takada K
    Anticancer Res; 1996; 16(1):301-4. PubMed ID: 8615625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor effect of 5-fluorouracil in combination with some additives which stimulate the formation of antineoplastic 5-fluorouracil nucleotides.
    Tamemasa O; Tezuka M
    Gan; 1983 Apr; 74(2):285-90. PubMed ID: 6407888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of anti-tumor effects of 5-fluorouracil on hepatocellular carcinoma by low-intensity ultrasound.
    Hu Z; Lv G; Li Y; Li E; Li H; Zhou Q; Yang B; Cao W
    J Exp Clin Cancer Res; 2016 Apr; 35():71. PubMed ID: 27102814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.